Ascendis Pharma A/S commenced trading of its ordinary shares on Nasdaq on April 20, 2026, replacing its American Depositary Shares listing under the same ticker symbol ASND.
Key takeaways
The company's ordinary shares began trading on The Nasdaq Global Select Market on April 20, 2026.
The ordinary shares trade under the same ticker symbol ASND as the previous ADS listing.
All outstanding ADSs were mandatorily exchanged for ordinary shares as of April 20, 2026.
The last trading day for ADSs on Nasdaq was April 17, 2026.
The company announced the mandatory exchange plan on April 8, 2026.